title: [Analysis of surgical treatment of 30 cases of small hepatocellular carcinoma in special position].
abstract: OBJECTIVE
  To investigate the resection technique for small hepatocellular carcinoma (SHCC) in special sites and discuss their outcome.
  
  
  METHODS
  Clinicopathological data of 30 patients with SHCC in special sites undergone liver resection were reviewed. There were 29 cases of hepatocellular carcinoma and 1 case of cholangiocarcinoma, confirmed by pathology. The tumor was close to the first porta hepatis in 8 cases, colse to the second porta hepatis in 15 cases, and close to the third porta hepatis in 7 cases. Twenty-five patients had one lesion, 4 patients had two and the other had three. The tumor diameter was (2.7 ± 1.2) cm.
  
  
  RESULTS
  No perioperative death occurred. The operation time was (279 ± 101) min, the mean intraoperative blood loss was 566 ml, and the postoperative hospitalization was (10.5 ± 2.7) days. The 1- and 3-year survival rates were 100% and 83.3%, respectively, and the 1- and 3-year disease free survival rates were 85.0% and 41.3%, respectively.
  
  
  CONCLUSIONS
  Although the surgery for SHCC in special sites is quite difficult and risky, surgical treatment is still safe with good perioperative management and is an effective treatment of SHCC in special sites.
authors.affiliation: Department of Abodominal Surgery, Chinese Academy of Medical Science and Peking Union Medical College, Cancer institute and Hospital, Beijing 100021, China.
authors.forename: Fan
authors.initials: F
authors.lastname: Wu
authors.forename: Wei-qi
authors.initials: WQ
authors.lastname: Rong
authors.forename: Li-ming
authors.initials: LM
authors.lastname: Wang
authors.forename: Yu-xin
authors.initials: YX
authors.lastname: Zhong
authors.forename: Li-guo
authors.initials: LG
authors.lastname: Liu
authors.forename: Jian-xiong
authors.initials: JX
authors.lastname: Wu
mesh_terms: D000328:Adult; D000368:Aged; D016063:Blood Loss, Surgical; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery*; D018281:Cholangiocarcinoma / Q000473:pathology / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D015996:Survival Rate